Loading...

SOHO 2026 Annual Meeting

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Poster Session

Thumbnail for GLP-1 Receptor Agonists and Major Clinical Outcomes in Adults With Classic Myeloproliferative Neoplasms and Type 2 Diabetes and/or Obesity: A Global Propensity Score-Matched Analysis

MPN - 1144

GLP-1 Receptor Agonists and Major Clinical Outcomes in Adults With Classic Myeloproliferative Neoplasms and Type 2 Diabetes and/or Obesity: A Global Propensity Score-Matched Analysis

Muluken Megiso

Poster Presenter: Muluken Megiso

Thumbnail for Quantifying the Patient Experience: A Systematic Review of JAK Inhibitor Impact on Symptom Scores, Health-Related Quality of Life, and Sleep in Myelofibrosis

MPN - 1147

Quantifying the Patient Experience: A Systematic Review of JAK Inhibitor Impact on Symptom Scores, Health-Related Quality of Life, and Sleep in Myelofibrosis

Amal Paul

Poster Presenter: Amal Paul

Thumbnail for Evaluation of Bone Formation Marker Changes in Summit, a Trial Assessing Bezuclastinib in Adults With Nonadvanced Systemic Mastocytosis: An Exploratory Analysis

MPN - 1148

Evaluation of Bone Formation Marker Changes in Summit, a Trial Assessing Bezuclastinib in Adults With Nonadvanced Systemic Mastocytosis: An Exploratory Analysis

Thanh D Hoang

Poster Presenter: Thanh D Hoang

Thumbnail for The Effect of Bezuclastinib on the Pathobiology of Mastocytosis: Changes in Bone Marrow Mast Cells, Tryptase, and KIT p.D816V Variant Allele Frequency From the Pivotal Summit Trial

MPN - 1154

The Effect of Bezuclastinib on the Pathobiology of Mastocytosis: Changes in Bone Marrow Mast Cells, Tryptase, and KIT p.D816V Variant Allele Frequency From the Pivotal Summit Trial

Dana Longo

Poster Presenter: Dana Longo

Thumbnail for The Effect of Bezuclastinib on the Pathobiology of Advanced Systemic Mastocytosis: Results from the Pivotal Apex Trial

MPN - 1161

The Effect of Bezuclastinib on the Pathobiology of Advanced Systemic Mastocytosis: Results from the Pivotal Apex Trial

Tram Le

Poster Presenter: Tram Le

Thumbnail for Efficacy and Safety of Bezuclastinib in Patients With Advanced Systemic Mastocytosis: Results From the Apex Study

MPN - 1187

Efficacy and Safety of Bezuclastinib in Patients With Advanced Systemic Mastocytosis: Results From the Apex Study

Cristina Papayannis

Poster Presenter: Cristina Papayannis

Thumbnail for Real-World Use of Pacritinib in Myelofibrosis: Results From the TriNetX Analysis on Patient Characteristics, Treatment Patterns, and Outcomes in Patients With Platelets =50Χ109/L at Initiation (TRIPAC)

MPN - 1200

Real-World Use of Pacritinib in Myelofibrosis: Results From the TriNetX Analysis on Patient Characteristics, Treatment Patterns, and Outcomes in Patients With Platelets =50Χ109/L at Initiation (TRIPAC)

Faizan Sattar

Poster Presenter: Faizan Sattar

Thumbnail for Discovery and Characterization of DMR-001, an Fc-Null, Half-Life-Optimized Monoclonal Antibody Selectively Targeting Mutant Calreticulin

MPN - 1206

Discovery and Characterization of DMR-001, an Fc-Null, Half-Life-Optimized Monoclonal Antibody Selectively Targeting Mutant Calreticulin

Mark Benton

Poster Presenter: Mark Benton

Thumbnail for Arterial and Venous Thrombosis in Myeloproliferative Neoplasm Hospitalizations: Distinct Associations With Mortality and Resource Utilization

MPN - 1235

Arterial and Venous Thrombosis in Myeloproliferative Neoplasm Hospitalizations: Distinct Associations With Mortality and Resource Utilization

Priyanka Nagdev

Poster Presenter: Priyanka Nagdev